newsTo support increasing biosimilar demand, Sandoz’s expected investment of $400m…
13 March 2023 | By Catherine Eckford (European Pharmaceutical Review)
To support increasing biosimilar demand, Sandoz’s expected investment of $400m will fund construction of a new biologics plant in Slovenia.